-
Prostate cancer: New combination therapy could reduce progression risk
Medical Mythbusting Commentary for March 27, 2023 [display_podcast] Source:Prostate cancer: New combination therapy could reduce progression risk Reference:TALAPRO-2 Supports First-Line Talazoparib/Enzalutamide in All-Comers With mCRPC
-
AI system developed to assist oncologists by predicting the effectiveness of breast cancer chemotherapy. This is just the beginning of AI forays into medicine.
Medical Mythbusting Commentary for February 8, 2023 [display_podcast] Source:AI can predict the effectiveness of breast cancer chemotherapy Reference:Cancer-Net BCa: Breast Cancer Pathologic Complete Response Prediction using Volumetric Deep Radiomic Features from Synthetic Correlated Diffusion Imaging
-
Study prompts doctors to renew recommendations for fallopian tube removal to prevent ovarian cancer
Medical Mythbusting Commentary for February 6, 2023 [display_podcast] Source:Study prompts doctors to renew recommendations for fallopian tube removal to prevent ovarian cancer Reference:Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trialOvarian Cancer Screening and Symptom Awareness Consensus Statement
-
Canadian doctors perform world-first delivery of treatment for inoperable brain tumour in kid using ultrasound
Medical Mythbusting Commentary for January 12, 2023 [display_podcast] Source:Canadian doctors perform world-first delivery of treatment for inoperable brain tumour in kid using ultrasound Reference:
-
Observational study of self-reported vitamin D intake and melanoma risk states, “In conclusion, regular use of vitamin D associates with fewer melanoma cases, when compared to non-use, but the causality between them is obscure.”
Medical Mythbusting Commentary for January 9, 2023 [display_podcast] Source:Vitamin D supplement found to lower risk of melanoma, new study finds Reference:Regular use of vitamin D supplement is associated with fewer melanoma cases compared to non-use: a cross-sectional study in 498 adult subjects at risk of skin cancers
-
Moderna and Merck report that a new mRNA anti-cancer vaccine under investigation used in combination with standard therapy to treat stage IV melanoma reduces risk of relapse compared to standard therapy alone.
Medical Mythbusting Commentary for December 14, 2022 [display_podcast] Source:Experimental mRNA cancer vaccine with immunotherapy reduces risk of melanoma returning, preliminary study finds Reference: Awaiting data release and publication
-
New insights into how prostate cancer protects itself from latest therapies after researchers uncover the gene responsible for this resistance while investigating new drug that circumvents these protective mechanisms.
Medical Mythbusting Commentary for November 28, 2022 [display_podcast] Source:Drug triggers immune cells to attack prostate cancer Reference:Inhibiting ACK1-mediated phosphorylation of C-terminal Src kinase counteracts prostate cancer immune checkpoint blockade resistance.
-
McGill University study shows that a shortened course of radiation therapy is safe and effective for men with high-risk prostate cancer
Medical Mythbusting Commentary for October 24, 2022 [display_podcast] Source:Shortened course of radiation therapy safe and effective for men with high-risk prostate cancer
-
Tweaking CAR-T activity with on/off switches may reduce cytokine release syndrome.
Medical Mythbusting Commentary for September 12, 2022 [display_podcast] Source:Immune cells engineered to battle cancer can be turned ‘on’ or ‘off’ Reference:High-performance multiplex drug-gated CAR circuits